Literature DB >> 16570802

[Study on reflux esophagitis treated by Tongjiang granule].

Xu-Dong Tang1, Hong-Mei Wu, Zhi-Bin Wang, Yan Shao, Yu-Chi Hu.   

Abstract

OBJECTIVE: To study the mechanism of Tongjiang granule on treating GERD.
METHOD: The rats in the model group received steel wire ring-cardiamyopexy. A steel wire ring was fixed firmly on cardia. The rats in the control group underwent the cardia-plasty plus pylori ligation plus stomach-empty intestine Roux-en-Y anastomosis. The rats were divided into six groups after operations at random, which were fed up respectively with Tongjiang granule of different dosage and perpulsid. No treatment groups were taken as control. RESULT: The experiment showed that Tongjiang granule could lighten or cure RE in the pathology, decrease the hydrochloric acid in gastric juice, in the meantime, increase the motilin in the animal blood. This study indicated that the effect of Tongjiang granule group from experimental research was better than that of the control group (perpulsid).
CONCLUSION: The effects of Tongjiang granule on treating GERD can be achieved by decreasing the hydrochloric acid in gastric juice, increasing the motilin in blood and promoting the gastric impetus in the animal experiment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570802

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  A randomized, controlled, double-blinded and double-dummy trial of the effect of tongjiang granule on the nonerosive reflux disease of and Gan-Wei incoordination syndrome.

Authors:  Bao-shuang Li; Zhen-hua Li; Xu-dong Tang; Li-ying Zhang; Ying-pan Zhao; Li-qun Bian; Yin-qiang Zhang; Ping Wang; Feng-yun Wang
Journal:  Chin J Integr Med       Date:  2011-05-25       Impact factor: 1.978

2.  Qualitative Analysis of Multiple Phytochemical Compounds in Tojapride Based on UHPLC Q-Exactive Orbitrap Mass Spectrometry.

Authors:  Liying Zhang; Shihan Qin; Sunv Tang; Shuai E; Kailin Li; Jing Li; Wei Cai; Lei Sun; Hui Li
Journal:  Molecules       Date:  2022-10-06       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.